Cite

HARVARD Citation

    Vigneron, C. et al. (2022). Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosis. Acta oncologica. pp. 608-610. [Online]. 
  
Back to record